Chronic immunosuppression, Australia antigenemia, and hepatitis.
D000818:Animals; D001379:Azathioprine / Q000009:adverse effects; D002353:Carrier State; D056486:Chemical and Drug Induced Liver Injury; D003168:Complement Fixation Tests; D003520:Cyclophosphamide / Q000627:therapeutic use; D006509:Hepatitis B / Q000150:complications*; D006511:Hepatitis B Antigens / Q000032:analysis*; D006801:Humans; D007106:Immune Sera; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D008111:Liver Function Tests; D011817:Rabbits / Q000276:immunology; D014184:Transplantation, Homologous
D006511:Hepatitis B Antigens; D007106:Immune Sera; D003520:Cyclophosphamide; D001379:Azathioprine